-
1
-
-
35848968871
-
Prevalence of chronic kidney disease in the United States
-
Coresh J., Selvin E., Stevens L.A., Manzi J., Kusek J.W., Eggers P., et al. Prevalence of chronic kidney disease in the United States. JAMA 2007, 298:2038-2047.
-
(2007)
JAMA
, vol.298
, pp. 2038-2047
-
-
Coresh, J.1
Selvin, E.2
Stevens, L.A.3
Manzi, J.4
Kusek, J.W.5
Eggers, P.6
-
3
-
-
84863115528
-
Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial
-
Thadhani R., Appelbaum E., Pritchett Y., Chang Y., Wenger J., Tamez H., et al. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA 2012, 307:674-684.
-
(2012)
JAMA
, vol.307
, pp. 674-684
-
-
Thadhani, R.1
Appelbaum, E.2
Pritchett, Y.3
Chang, Y.4
Wenger, J.5
Tamez, H.6
-
4
-
-
68949114585
-
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorders (CKD-MBD)
-
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group
-
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorders (CKD-MBD). Kidney Int Suppl 2009, 113:S1-S130. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group.
-
(2009)
Kidney Int Suppl
, vol.113
-
-
-
5
-
-
79957870135
-
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
-
Isakova T., Wahl P., Vargas G.S., Gutierrez O.M., Scialla J., Xie H., et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 2011, 79:1370-1378.
-
(2011)
Kidney Int
, vol.79
, pp. 1370-1378
-
-
Isakova, T.1
Wahl, P.2
Vargas, G.S.3
Gutierrez, O.M.4
Scialla, J.5
Xie, H.6
-
6
-
-
0019890721
-
The horse-racing effect
-
Peto R. The horse-racing effect. Lancet 1981, 2:467-468.
-
(1981)
Lancet
, vol.2
, pp. 467-468
-
-
Peto, R.1
-
7
-
-
84860732514
-
Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol
-
Isakova T., Xie H., Barchi-Chung A., Smith K., Sowden N., Epstein M., et al. Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol. Clin J Am Soc Nephrol 2012, 7:820-828.
-
(2012)
Clin J Am Soc Nephrol
, vol.7
, pp. 820-828
-
-
Isakova, T.1
Xie, H.2
Barchi-Chung, A.3
Smith, K.4
Sowden, N.5
Epstein, M.6
-
8
-
-
80655135433
-
Fibroblast growth factor 23 in patients undergoing peritoneal dialysis
-
Isakova T., Xie H., Barchi-Chung A., Vargas G., Sowden N., Houston J., et al. Fibroblast growth factor 23 in patients undergoing peritoneal dialysis. Clin J Am Soc Nephrol 2011, 6:2688-2695.
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, pp. 2688-2695
-
-
Isakova, T.1
Xie, H.2
Barchi-Chung, A.3
Vargas, G.4
Sowden, N.5
Houston, J.6
-
9
-
-
3543139492
-
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
-
Block G.A., Klassen P.S., Lazarus J.M., Ofsthun N., Lowrie E.G., Chertow G.M. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004, 15:2208-2218.
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 2208-2218
-
-
Block, G.A.1
Klassen, P.S.2
Lazarus, J.M.3
Ofsthun, N.4
Lowrie, E.G.5
Chertow, G.M.6
-
10
-
-
20544433192
-
Serum phosphate levels and mortality risk among people with chronic kidney disease
-
Kestenbaum B., Sampson J.N., Rudser K.D., Patterson D.J., Seliger S.L., Young B., et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 2005, 16:520-528.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 520-528
-
-
Kestenbaum, B.1
Sampson, J.N.2
Rudser, K.D.3
Patterson, D.J.4
Seliger, S.L.5
Young, B.6
-
11
-
-
36048942723
-
High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients
-
Voormolen N., Noordzij M., Grootendorst D.C., Beetz I., Sijpkens Y.W., van Manen J.G., et al. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 2007, 22:2909-2916.
-
(2007)
Nephrol Dial Transplant
, vol.22
, pp. 2909-2916
-
-
Voormolen, N.1
Noordzij, M.2
Grootendorst, D.C.3
Beetz, I.4
Sijpkens, Y.W.5
van Manen, J.G.6
-
12
-
-
23944460805
-
Relationship of phosphorus and calcium-phosphorus product with mortality in CKD
-
Menon V., Greene T., Pereira A.A., Wang X., Beck G.J., Kusek J.W., et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. Am J Kidney Dis 2005, 46:455-463.
-
(2005)
Am J Kidney Dis
, vol.46
, pp. 455-463
-
-
Menon, V.1
Greene, T.2
Pereira, A.A.3
Wang, X.4
Beck, G.J.5
Kusek, J.W.6
-
13
-
-
77950801451
-
Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease
-
Kovesdy C.P., Anderson J.E., Kalantar-Zadeh K. Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease. Clin Nephrol 2010, 73:268-275.
-
(2010)
Clin Nephrol
, vol.73
, pp. 268-275
-
-
Kovesdy, C.P.1
Anderson, J.E.2
Kalantar-Zadeh, K.3
-
14
-
-
79952604526
-
Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis
-
Palmer S.C., Hayen A., Macaskill P., Pellegrini F., Craig J.C., Elder G.J., et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 2011, 305:1119-1127.
-
(2011)
JAMA
, vol.305
, pp. 1119-1127
-
-
Palmer, S.C.1
Hayen, A.2
Macaskill, P.3
Pellegrini, F.4
Craig, J.C.5
Elder, G.J.6
-
15
-
-
33749261979
-
Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease
-
Norris K.C., Greene T., Kopple J., Lea J., Lewis J., Lipkowitz M., et al. Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease. J Am Soc Nephrol 2006, 17:2928-2936.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 2928-2936
-
-
Norris, K.C.1
Greene, T.2
Kopple, J.3
Lea, J.4
Lewis, J.5
Lipkowitz, M.6
-
16
-
-
33947320099
-
Association of disorders in mineral metabolism with progression of chronic kidney disease
-
Schwarz S., Trivedi B.K., Kalantar-Zadeh K., Kovesdy C.P. Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol 2006, 1:825-831.
-
(2006)
Clin J Am Soc Nephrol
, vol.1
, pp. 825-831
-
-
Schwarz, S.1
Trivedi, B.K.2
Kalantar-Zadeh, K.3
Kovesdy, C.P.4
-
17
-
-
79955555142
-
Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction
-
Bellasi A., Mandreoli M., Baldrati L., Corradini M., Di Nicolo P., Malmusi G., et al. Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction. Clin J Am Soc Nephrol 2011, 6:883-891.
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, pp. 883-891
-
-
Bellasi, A.1
Mandreoli, M.2
Baldrati, L.3
Corradini, M.4
Di Nicolo, P.5
Malmusi, G.6
-
18
-
-
80053517709
-
FGF23 associates with death, cardiovascular events, and initiation of chronic dialysis
-
Kendrick J., Cheung A.K., Kaufman J.S., Greene T., Roberts W.L., Smits G., et al. FGF23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol 2011, 22:1913-1922.
-
(2011)
J Am Soc Nephrol
, vol.22
, pp. 1913-1922
-
-
Kendrick, J.1
Cheung, A.K.2
Kaufman, J.S.3
Greene, T.4
Roberts, W.L.5
Smits, G.6
-
19
-
-
78649445874
-
Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study
-
Landray M.J., Emberson J.R., Blackwell L., Dasgupta T., Zakeri R., Morgan M.D., et al. Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study. Am J Kidney Dis 2010, 56:1082-1094.
-
(2010)
Am J Kidney Dis
, vol.56
, pp. 1082-1094
-
-
Landray, M.J.1
Emberson, J.R.2
Blackwell, L.3
Dasgupta, T.4
Zakeri, R.5
Morgan, M.D.6
-
20
-
-
79955015634
-
A predictive model for progression of chronic kidney disease to kidney failure
-
Tangri N., Stevens L.A., Griffith J., Tighiouart H., Djurdjev O., Naimark D., et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA 2011, 305:1553-1559.
-
(2011)
JAMA
, vol.305
, pp. 1553-1559
-
-
Tangri, N.1
Stevens, L.A.2
Griffith, J.3
Tighiouart, H.4
Djurdjev, O.5
Naimark, D.6
-
21
-
-
80053502175
-
Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition
-
Zoccali C., Ruggenenti P., Perna A., Leonardis D., Tripepi R., Tripepi G., et al. Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. J Am Soc Nephrol 2011, 22:1923-1930.
-
(2011)
J Am Soc Nephrol
, vol.22
, pp. 1923-1930
-
-
Zoccali, C.1
Ruggenenti, P.2
Perna, A.3
Leonardis, D.4
Tripepi, R.5
Tripepi, G.6
-
22
-
-
80053525135
-
Phosphate REINs in the renoprotective benefit of ACE inhibition
-
Block G.A., Wolf M. Phosphate REINs in the renoprotective benefit of ACE inhibition. J Am Soc Nephrol 2011, 22:1777-1779.
-
(2011)
J Am Soc Nephrol
, vol.22
, pp. 1777-1779
-
-
Block, G.A.1
Wolf, M.2
-
23
-
-
80053211737
-
Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease
-
O'Seaghdha C.M., Hwang S.J., Muntner P., Melamed M.L., Fox C.S. Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease. Nephrol Dial Transplant 2011, 26:2885-2890.
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 2885-2890
-
-
O'Seaghdha, C.M.1
Hwang, S.J.2
Muntner, P.3
Melamed, M.L.4
Fox, C.S.5
-
24
-
-
34248522825
-
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community
-
Dhingra R., Sullivan L.M., Fox C.S., Wang T.J., D'Agostino R.B., Gaziano J.M., et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007, 167:879-885.
-
(2007)
Arch Intern Med
, vol.167
, pp. 879-885
-
-
Dhingra, R.1
Sullivan, L.M.2
Fox, C.S.3
Wang, T.J.4
D'Agostino, R.B.5
Gaziano, J.M.6
-
25
-
-
27444436252
-
Relation between serum phosphate level and cardiovascular event rate in people with coronary disease
-
Tonelli M., Sacks F., Pfeffer M., Gao Z., Curhan G. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005, 112:2627.
-
(2005)
Circulation
, vol.112
, pp. 2627
-
-
Tonelli, M.1
Sacks, F.2
Pfeffer, M.3
Gao, Z.4
Curhan, G.5
-
26
-
-
63049135405
-
Serum phosphorus and cardiovascular mortality in type 2 diabetes
-
Chonchol M., Dale R., Schrier R.W., Estacio R. Serum phosphorus and cardiovascular mortality in type 2 diabetes. Am J Med 2009, 122:380-386.
-
(2009)
Am J Med
, vol.122
, pp. 380-386
-
-
Chonchol, M.1
Dale, R.2
Schrier, R.W.3
Estacio, R.4
-
27
-
-
67649739089
-
Dietary phosphorus acutely impairs endothelial function
-
Shuto E., Taketani Y., Tanaka R., Harada N., Isshiki M., Sato M., et al. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol 2009, 20:1504-1512.
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 1504-1512
-
-
Shuto, E.1
Taketani, Y.2
Tanaka, R.3
Harada, N.4
Isshiki, M.5
Sato, M.6
-
28
-
-
84855827125
-
Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial
-
Yilmaz M.I., Sonmez A., Saglam M., Yaman H., Kilic S., Eyileten T., et al. Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial. Am J Kidney Dis 2012, 59:177-185.
-
(2012)
Am J Kidney Dis
, vol.59
, pp. 177-185
-
-
Yilmaz, M.I.1
Sonmez, A.2
Saglam, M.3
Yaman, H.4
Kilic, S.5
Eyileten, T.6
-
29
-
-
0035092519
-
Parathormone, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients
-
Strozecki P., Adamowicz A., Nartowicz E., Odrowaz-Sypniewska G., Wlodarczyk Z., Manitius J. Parathormone, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients. Ren Fail 2001, 23:115-126.
-
(2001)
Ren Fail
, vol.23
, pp. 115-126
-
-
Strozecki, P.1
Adamowicz, A.2
Nartowicz, E.3
Odrowaz-Sypniewska, G.4
Wlodarczyk, Z.5
Manitius, J.6
-
30
-
-
0035741826
-
Changes in heart rate variability in chronic uremic patients during ultrafiltration and hemodialysis
-
Galetta F., Cupisti A., Franzoni F., Morelli E., Caprioli R., Rindi P., et al. Changes in heart rate variability in chronic uremic patients during ultrafiltration and hemodialysis. Blood Purif 2001, 19:395-400.
-
(2001)
Blood Purif
, vol.19
, pp. 395-400
-
-
Galetta, F.1
Cupisti, A.2
Franzoni, F.3
Morelli, E.4
Caprioli, R.5
Rindi, P.6
-
31
-
-
60449096473
-
Serum phosphate and left ventricular hypertrophy in young adults: the coronary artery risk development in young adults study
-
Foley R.N., Collins A.J., Herzog C.A., Ishani A., Kalra P.A. Serum phosphate and left ventricular hypertrophy in young adults: the coronary artery risk development in young adults study. Kidney Blood Press Res 2009, 32:37-44.
-
(2009)
Kidney Blood Press Res
, vol.32
, pp. 37-44
-
-
Foley, R.N.1
Collins, A.J.2
Herzog, C.A.3
Ishani, A.4
Kalra, P.A.5
-
32
-
-
78651409106
-
Vitamin D receptor activation and left ventricular hypertrophy in advanced kidney disease
-
Thadhani R., Appelbaum E., Chang Y., Pritchett Y., Bhan I., Agarwal R., et al. Vitamin D receptor activation and left ventricular hypertrophy in advanced kidney disease. Am J Nephrol 2011, 33:139-149.
-
(2011)
Am J Nephrol
, vol.33
, pp. 139-149
-
-
Thadhani, R.1
Appelbaum, E.2
Chang, Y.3
Pritchett, Y.4
Bhan, I.5
Agarwal, R.6
-
33
-
-
84555187981
-
Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: a cardiac magnetic resonance study
-
Chue C.D., Edwards N.C., Moody W.E., Steeds R.P., Townend J.N., Ferro C.J. Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: a cardiac magnetic resonance study. Heart 2012, 98:219-224.
-
(2012)
Heart
, vol.98
, pp. 219-224
-
-
Chue, C.D.1
Edwards, N.C.2
Moody, W.E.3
Steeds, R.P.4
Townend, J.N.5
Ferro, C.J.6
-
34
-
-
84875724595
-
Dietary phosphorus is associated with greater left ventricular mass
-
In press
-
Yamamoto K.T., Robinson-Cohen C., de Oliveira M.C., Kostina A., Nettleton J.A., Ix J.H., et al. Dietary phosphorus is associated with greater left ventricular mass. Kidney Int 2013, In press.
-
(2013)
Kidney Int
-
-
Yamamoto, K.T.1
Robinson-Cohen, C.2
de Oliveira, M.C.3
Kostina, A.4
Nettleton, J.A.5
Ix, J.H.6
-
35
-
-
33644812878
-
Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study
-
Ayus J.C., Mizani M.R., Achinger S.G., Thadhani R., Go A.S., Lee S. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol 2005, 16:2778-2788.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 2778-2788
-
-
Ayus, J.C.1
Mizani, M.R.2
Achinger, S.G.3
Thadhani, R.4
Go, A.S.5
Lee, S.6
-
36
-
-
33845241514
-
Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor?
-
Achinger S.G., Ayus J.C. Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor?. J Am Soc Nephrol 2006, 17:S255-S261.
-
(2006)
J Am Soc Nephrol
, vol.17
-
-
Achinger, S.G.1
Ayus, J.C.2
-
37
-
-
34548772315
-
Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial
-
Culleton B.F., Walsh M., Klarenbach S.W., Mortis G., Scott-Douglas N., Quinn R.R., et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 2007, 298:1291-1299.
-
(2007)
JAMA
, vol.298
, pp. 1291-1299
-
-
Culleton, B.F.1
Walsh, M.2
Klarenbach, S.W.3
Mortis, G.4
Scott-Douglas, N.5
Quinn, R.R.6
-
38
-
-
66349097180
-
Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease
-
Gutierrez O.M., Januzzi J.L., Isakova T., Laliberte K., Smith K., Collerone G., et al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 2009, 119:2545-2552.
-
(2009)
Circulation
, vol.119
, pp. 2545-2552
-
-
Gutierrez, O.M.1
Januzzi, J.L.2
Isakova, T.3
Laliberte, K.4
Smith, K.5
Collerone, G.6
-
39
-
-
80555148939
-
FGF23 induces left ventricular hypertrophy
-
Faul C., Amaral A.P., Oskouei B., Hu M.C., Sloan A., Isakova T., et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011, 121:4393-4408.
-
(2011)
J Clin Invest
, vol.121
, pp. 4393-4408
-
-
Faul, C.1
Amaral, A.P.2
Oskouei, B.3
Hu, M.C.4
Sloan, A.5
Isakova, T.6
-
40
-
-
18144402703
-
Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study
-
Young E.W., Albert J.M., Satayathum S., Goodkin D.A., Pisoni R.L., Akiba T., et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005, 67:1179-1187.
-
(2005)
Kidney Int
, vol.67
, pp. 1179-1187
-
-
Young, E.W.1
Albert, J.M.2
Satayathum, S.3
Goodkin, D.A.4
Pisoni, R.L.5
Akiba, T.6
-
41
-
-
33745210682
-
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients
-
Kalantar-Zadeh K., Kuwae N., Regidor D.L., Kovesdy C.P., Kilpatrick R.D., Shinaberger C.S., et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006, 70:771-780.
-
(2006)
Kidney Int
, vol.70
, pp. 771-780
-
-
Kalantar-Zadeh, K.1
Kuwae, N.2
Regidor, D.L.3
Kovesdy, C.P.4
Kilpatrick, R.D.5
Shinaberger, C.S.6
-
42
-
-
78650322250
-
Serum phosphate and mortality in patients with chronic kidney disease
-
Eddington H., Hoefield R., Sinha S., Chrysochou C., Lane B., Foley R.N., et al. Serum phosphate and mortality in patients with chronic kidney disease. Clin J Am Soc Nephrol 2010, 5:2251-2257.
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, pp. 2251-2257
-
-
Eddington, H.1
Hoefield, R.2
Sinha, S.3
Chrysochou, C.4
Lane, B.5
Foley, R.N.6
-
43
-
-
77958471266
-
Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD
-
Kovesdy C.P., Kuchmak O., Lu J.L., Kalantar-Zadeh K. Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD. Am J Kidney Dis 2010, 56:842.
-
(2010)
Am J Kidney Dis
, vol.56
, pp. 842
-
-
Kovesdy, C.P.1
Kuchmak, O.2
Lu, J.L.3
Kalantar-Zadeh, K.4
-
44
-
-
59949084660
-
Phosphorus binders and survival on hemodialysis
-
Isakova T., Gutierrez O.M., Chang Y., Shah A., Tamez H., Smith K., et al. Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol 2009, 20:388-396.
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 388-396
-
-
Isakova, T.1
Gutierrez, O.M.2
Chang, Y.3
Shah, A.4
Tamez, H.5
Smith, K.6
-
45
-
-
33644875696
-
Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure
-
Markowitz G.S., Stokes M.B., Radhakrishnan J., D'Agati V.D. Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. J Am Soc Nephrol 2005, 16:3389-3396.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 3389-3396
-
-
Markowitz, G.S.1
Stokes, M.B.2
Radhakrishnan, J.3
D'Agati, V.D.4
-
46
-
-
0021847511
-
Calcium metabolism in uremic nephrocalcinosis: preventive effect of verapamil
-
Goligorsky M.S., Chaimovitz C., Rapoport J., Goldstein J., Kol R. Calcium metabolism in uremic nephrocalcinosis: preventive effect of verapamil. Kidney Int 1985, 27:774-779.
-
(1985)
Kidney Int
, vol.27
, pp. 774-779
-
-
Goligorsky, M.S.1
Chaimovitz, C.2
Rapoport, J.3
Goldstein, J.4
Kol, R.5
-
47
-
-
0028205842
-
Increased nephron oxygen consumption: potential role in progression of chronic renal disease
-
Schrier R.W., Shapiro J.I., Chan L., Harris D.C. Increased nephron oxygen consumption: potential role in progression of chronic renal disease. Am J Kidney Dis 1994, 23:176-182.
-
(1994)
Am J Kidney Dis
, vol.23
, pp. 176-182
-
-
Schrier, R.W.1
Shapiro, J.I.2
Chan, L.3
Harris, D.C.4
-
48
-
-
4644221457
-
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
-
Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305.
-
(2004)
N Engl J Med
, vol.351
, pp. 1296-1305
-
-
Go, A.S.1
Chertow, G.M.2
Fan, D.3
McCulloch, C.E.4
Hsu, C.Y.5
-
49
-
-
1942506539
-
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies
-
Weiner D.E., Tighiouart H., Amin M.G., Stark P.C., MacLeod B., Griffith J.L., et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004, 15:1307-1315.
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 1307-1315
-
-
Weiner, D.E.1
Tighiouart, H.2
Amin, M.G.3
Stark, P.C.4
MacLeod, B.5
Griffith, J.L.6
-
50
-
-
21644453113
-
Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure
-
Neves K.R., Graciolli F.G., dos Reis L.M., Pasqualucci C.A., Moyses R.M., Jorgetti V. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure. Kidney Int 2004, 66:2237-2244.
-
(2004)
Kidney Int
, vol.66
, pp. 2237-2244
-
-
Neves, K.R.1
Graciolli, F.G.2
dos Reis, L.M.3
Pasqualucci, C.A.4
Moyses, R.M.5
Jorgetti, V.6
-
51
-
-
43749124436
-
Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease
-
Kovesdy C.P., Ahmadzadeh S., Anderson J.E., Kalantar-Zadeh K. Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int 2008, 73:1296-1302.
-
(2008)
Kidney Int
, vol.73
, pp. 1296-1302
-
-
Kovesdy, C.P.1
Ahmadzadeh, S.2
Anderson, J.E.3
Kalantar-Zadeh, K.4
-
52
-
-
67649873051
-
Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients
-
Schumock G.T., Andress D.L., Marx S.E., Sterz R., Joyce A.T., Kalantar-Zadeh K. Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients. Nephron Clin Pract 2009, 113:c54-c61.
-
(2009)
Nephron Clin Pract
, vol.113
-
-
Schumock, G.T.1
Andress, D.L.2
Marx, S.E.3
Sterz, R.4
Joyce, A.T.5
Kalantar-Zadeh, K.6
-
53
-
-
70349969936
-
Elevated serum PTH is independently associated with poor outcomes in older patients with hip fracture and vitamin D inadequacy
-
Fisher A., Goh S., Srikusalanukul W., Davis M. Elevated serum PTH is independently associated with poor outcomes in older patients with hip fracture and vitamin D inadequacy. Calcif Tissue Int 2009, 85:301-309.
-
(2009)
Calcif Tissue Int
, vol.85
, pp. 301-309
-
-
Fisher, A.1
Goh, S.2
Srikusalanukul, W.3
Davis, M.4
-
54
-
-
70449532993
-
Parathyroid hormone as a mortality predictor in frail aged inpatients
-
Bjorkman M., Sorva A., Tilvis R. Parathyroid hormone as a mortality predictor in frail aged inpatients. Gerontology 2009, 55:601-606.
-
(2009)
Gerontology
, vol.55
, pp. 601-606
-
-
Bjorkman, M.1
Sorva, A.2
Tilvis, R.3
-
55
-
-
80052606610
-
Serum 25hydroxyvitamin D and change in estimated glomerular filtration rate
-
de Boer I.H., Katz R., Chonchol M., Ix J.H., Sarnak M.J., Shlipak M.G., et al. Serum 25hydroxyvitamin D and change in estimated glomerular filtration rate. Clin J Am Soc Nephrol 2011, 6:2141-2149.
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, pp. 2141-2149
-
-
de Boer, I.H.1
Katz, R.2
Chonchol, M.3
Ix, J.H.4
Sarnak, M.J.5
Shlipak, M.G.6
-
56
-
-
79955603792
-
Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality
-
Wolf M., Molnar M.Z., Amaral A.P., Czira M.E., Rudas A., Ujszaszi A., et al. Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J Am Soc Nephrol 2011, 22:956-966.
-
(2011)
J Am Soc Nephrol
, vol.22
, pp. 956-966
-
-
Wolf, M.1
Molnar, M.Z.2
Amaral, A.P.3
Czira, M.E.4
Rudas, A.5
Ujszaszi, A.6
-
57
-
-
61749084092
-
Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP)
-
Bhuriya R., Li S., Chen S.C., McCullough P.A., Bakris G.L. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2009, 53:S3-S10.
-
(2009)
Am J Kidney Dis
, vol.53
-
-
Bhuriya, R.1
Li, S.2
Chen, S.C.3
McCullough, P.A.4
Bakris, G.L.5
-
58
-
-
83155180251
-
Vitamin D, parathyroid hormone, and sudden cardiac death: results from the Cardiovascular Health Study
-
Deo R., Katz R., Shlipak M.G., Sotoodehnia N., Psaty B.M., Sarnak M.J., et al. Vitamin D, parathyroid hormone, and sudden cardiac death: results from the Cardiovascular Health Study. Hypertension 2011, 58:1021-1028.
-
(2011)
Hypertension
, vol.58
, pp. 1021-1028
-
-
Deo, R.1
Katz, R.2
Shlipak, M.G.3
Sotoodehnia, N.4
Psaty, B.M.5
Sarnak, M.J.6
-
59
-
-
80051619756
-
Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?
-
Anderson J.L., Vanwoerkom R.C., Horne B.D., Bair T.L., May H.T., Lappe D.L., et al. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?. Am Heart J 2011, 162:331-3319.e2.
-
(2011)
Am Heart J
, vol.162
-
-
Anderson, J.L.1
Vanwoerkom, R.C.2
Horne, B.D.3
Bair, T.L.4
May, H.T.5
Lappe, D.L.6
-
60
-
-
77958547571
-
Plasma parathyroid hormone and risk of congestive heart failure in the community
-
Hagstrom E., Ingelsson E., Sundstrom J., Hellman P., Larsson T.E., Berglund L., et al. Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur J Heart Fail 2010, 12:1186-1192.
-
(2010)
Eur J Heart Fail
, vol.12
, pp. 1186-1192
-
-
Hagstrom, E.1
Ingelsson, E.2
Sundstrom, J.3
Hellman, P.4
Larsson, T.E.5
Berglund, L.6
-
61
-
-
0242403215
-
Parathyroid hormone and left ventricular hypertrophy
-
Saleh F.N., Schirmer H., Sundsfjord J., Jorde R. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 2003, 24:2054-2060.
-
(2003)
Eur Heart J
, vol.24
, pp. 2054-2060
-
-
Saleh, F.N.1
Schirmer, H.2
Sundsfjord, J.3
Jorde, R.4
-
62
-
-
67649223663
-
Plasma parathyroid hormone and the risk of cardiovascular mortality in the community
-
Hagstrom E., Hellman P., Larsson T.E., Ingelsson E., Berglund L., Sundstrom J., et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009, 119:2765-2771.
-
(2009)
Circulation
, vol.119
, pp. 2765-2771
-
-
Hagstrom, E.1
Hellman, P.2
Larsson, T.E.3
Ingelsson, E.4
Berglund, L.5
Sundstrom, J.6
-
63
-
-
79958724181
-
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease
-
Isakova T., Xie H., Yang W., Xie D., Anderson A.H., Scialla J., et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 2011, 305:2432-2439.
-
(2011)
JAMA
, vol.305
, pp. 2432-2439
-
-
Isakova, T.1
Xie, H.2
Yang, W.3
Xie, D.4
Anderson, A.H.5
Scialla, J.6
-
64
-
-
84862115472
-
PTH-a particularly tricky hormone: why measure it at all in kidney patients?
-
Garrett G., Sardiwal S., Lamb E.J., Goldsmith D.J. PTH-a particularly tricky hormone: why measure it at all in kidney patients?. Clin J Am Soc Nephrol 2012, 7:1-14.
-
(2012)
Clin J Am Soc Nephrol
, vol.7
, pp. 1-14
-
-
Garrett, G.1
Sardiwal, S.2
Lamb, E.J.3
Goldsmith, D.J.4
-
65
-
-
83055172414
-
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
-
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003, 42:S1-S201.
-
(2003)
Am J Kidney Dis
, vol.42
-
-
-
66
-
-
0019459801
-
Effect of parathyroid hormone on rat heart cells
-
Bogin E., Massry S.G., Harary I. Effect of parathyroid hormone on rat heart cells. J Clin Invest 1981, 67:1215-1227.
-
(1981)
J Clin Invest
, vol.67
, pp. 1215-1227
-
-
Bogin, E.1
Massry, S.G.2
Harary, I.3
-
67
-
-
0030687595
-
Effects of excess PTH on nonclassical target organs
-
Bro S., Olgaard K. Effects of excess PTH on nonclassical target organs. Am J Kidney Dis 1997, 30:606-620.
-
(1997)
Am J Kidney Dis
, vol.30
, pp. 606-620
-
-
Bro, S.1
Olgaard, K.2
-
68
-
-
77957993384
-
PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop
-
Lavi-Moshayoff V., Wasserman G., Meir T., Silver J., Naveh-Many T. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am J Physiol Renal Physiol 2010, 299:F882-F889.
-
(2010)
Am J Physiol Renal Physiol
, vol.299
-
-
Lavi-Moshayoff, V.1
Wasserman, G.2
Meir, T.3
Silver, J.4
Naveh-Many, T.5
-
69
-
-
80052303008
-
Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo
-
Rhee Y., Bivi N., Farrow E., Lezcano V., Plotkin L.I., White K.E., et al. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. Bone 2011, 49:636-643.
-
(2011)
Bone
, vol.49
, pp. 636-643
-
-
Rhee, Y.1
Bivi, N.2
Farrow, E.3
Lezcano, V.4
Plotkin, L.I.5
White, K.E.6
-
70
-
-
34447514029
-
Vitamin D deficiency
-
Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
-
(2007)
N Engl J Med
, vol.357
, pp. 266-281
-
-
Holick, M.F.1
-
71
-
-
58149156441
-
Vitamin D levels and patient outcome in chronic kidney disease
-
Ravani P., Malberti F., Tripepi G., Pecchini P., Cutrupi S., Pizzini P., et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 2009, 75:88-95.
-
(2009)
Kidney Int
, vol.75
, pp. 88-95
-
-
Ravani, P.1
Malberti, F.2
Tripepi, G.3
Pecchini, P.4
Cutrupi, S.5
Pizzini, P.6
-
72
-
-
72049115797
-
25hydroxyvitamin D levels, race, and the progression of kidney disease
-
Melamed M.L., Astor B., Michos E.D., Hostetter T.H., Powe N.R., Muntner P. 25hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol 2009, 20:2631-2639.
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 2631-2639
-
-
Melamed, M.L.1
Astor, B.2
Michos, E.D.3
Hostetter, T.H.4
Powe, N.R.5
Muntner, P.6
-
73
-
-
34250762524
-
25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III)
-
de Boer I.H., Ioannou G.N., Kestenbaum B., Brunzell J.D., Weiss N.S. 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 2007, 50:69-77.
-
(2007)
Am J Kidney Dis
, vol.50
, pp. 69-77
-
-
de Boer, I.H.1
Ioannou, G.N.2
Kestenbaum, B.3
Brunzell, J.D.4
Weiss, N.S.5
-
74
-
-
79959230591
-
Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions
-
Isakova T., Gutierrez O.M., Patel N.M., Andress D.L., Wolf M., Levin A. Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. J Ren Nutr 2011, 21:295-302.
-
(2011)
J Ren Nutr
, vol.21
, pp. 295-302
-
-
Isakova, T.1
Gutierrez, O.M.2
Patel, N.M.3
Andress, D.L.4
Wolf, M.5
Levin, A.6
-
75
-
-
78149359262
-
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
-
de Zeeuw D., Agarwal R., Amdahl M., Audhya P., Coyne D., Garimella T., et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 2010, 376:1543-1551.
-
(2010)
Lancet
, vol.376
, pp. 1543-1551
-
-
de Zeeuw, D.1
Agarwal, R.2
Amdahl, M.3
Audhya, P.4
Coyne, D.5
Garimella, T.6
-
76
-
-
69549133632
-
Prospective study of serum 25hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults
-
Ginde A.A., Scragg R., Schwartz R.S., Camargo C.A. Prospective study of serum 25hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 2009, 57:1595-1603.
-
(2009)
J Am Geriatr Soc
, vol.57
, pp. 1595-1603
-
-
Ginde, A.A.1
Scragg, R.2
Schwartz, R.S.3
Camargo, C.A.4
-
77
-
-
77956964689
-
Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population
-
Anderson J.L., May H.T., Horne B.D., Bair T.L., Hall N.L., Carlquist J.F., et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010, 106:963-968.
-
(2010)
Am J Cardiol
, vol.106
, pp. 963-968
-
-
Anderson, J.L.1
May, H.T.2
Horne, B.D.3
Bair, T.L.4
Hall, N.L.5
Carlquist, J.F.6
-
78
-
-
45149090726
-
25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study
-
Giovannucci E., Liu Y., Hollis B.W., Rimm E.B. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008, 168:1174-1180.
-
(2008)
Arch Intern Med
, vol.168
, pp. 1174-1180
-
-
Giovannucci, E.1
Liu, Y.2
Hollis, B.W.3
Rimm, E.B.4
-
79
-
-
41049096380
-
Vitamin D deficiency and risk of cardiovascular disease
-
Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117:503-511.
-
(2008)
Circulation
, vol.117
, pp. 503-511
-
-
Wang, T.J.1
Pencina, M.J.2
Booth, S.L.3
Jacques, P.F.4
Ingelsson, E.5
Lanier, K.6
-
80
-
-
77956934530
-
Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients
-
Drechsler C., Pilz S., Obermayer-Pietsch B., Verduijn M., Tomaschitz A., Krane V., et al. Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J 2010, 31:2253-2261.
-
(2010)
Eur Heart J
, vol.31
, pp. 2253-2261
-
-
Drechsler, C.1
Pilz, S.2
Obermayer-Pietsch, B.3
Verduijn, M.4
Tomaschitz, A.5
Krane, V.6
-
81
-
-
84155162421
-
Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients
-
Chitalia N., Recio-Mayoral A., Kaski J.C., Banerjee D. Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients. Atherosclerosis 2012, 220:265-268.
-
(2012)
Atherosclerosis
, vol.220
, pp. 265-268
-
-
Chitalia, N.1
Recio-Mayoral, A.2
Kaski, J.C.3
Banerjee, D.4
-
82
-
-
79954729172
-
Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults
-
Harris R.A., Pedersen-White J., Guo D.H., Stallmann-Jorgensen I.S., Keeton D., Huang Y., et al. Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults. Am J Hypertens 2011, 24:557-562.
-
(2011)
Am J Hypertens
, vol.24
, pp. 557-562
-
-
Harris, R.A.1
Pedersen-White, J.2
Guo, D.H.3
Stallmann-Jorgensen, I.S.4
Keeton, D.5
Huang, Y.6
-
83
-
-
84888290186
-
Treatment of 25-OH vitamin D deficiency in older men with chronic kidney disease stages 3 and 4 is associated with reduction in cardiovascular events
-
In press
-
Lishmanov A., Dorairajan S., Pak Y., Chaudhary K., Chockalingam A. Treatment of 25-OH vitamin D deficiency in older men with chronic kidney disease stages 3 and 4 is associated with reduction in cardiovascular events. Am J Ther 2011, In press.
-
(2011)
Am J Ther
-
-
Lishmanov, A.1
Dorairajan, S.2
Pak, Y.3
Chaudhary, K.4
Chockalingam, A.5
-
84
-
-
77952316154
-
Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters
-
Matias P.J., Jorge C., Ferreira C., Borges M., Aires I., Amaral T., et al. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol 2010, 5:905-911.
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, pp. 905-911
-
-
Matias, P.J.1
Jorge, C.2
Ferreira, C.3
Borges, M.4
Aires, I.5
Amaral, T.6
-
85
-
-
70350077680
-
Chronic kidney disease, hypovitaminosis D, and mortality in the United States
-
Mehrotra R., Kermah D.A., Salusky I.B., Wolf M.S., Thadhani R.I., Chiu Y.W., et al. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int 2009, 76:977.
-
(2009)
Kidney Int
, vol.76
, pp. 977
-
-
Mehrotra, R.1
Kermah, D.A.2
Salusky, I.B.3
Wolf, M.S.4
Thadhani, R.I.5
Chiu, Y.W.6
-
86
-
-
80053053192
-
Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD
-
Navaneethan S.D., Schold J.D., Arrigain S., Jolly S.E., Jain A., Schreiber M.J., et al. Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD. Am J Kidney Dis 2011, 58:536-543.
-
(2011)
Am J Kidney Dis
, vol.58
, pp. 536-543
-
-
Navaneethan, S.D.1
Schold, J.D.2
Arrigain, S.3
Jolly, S.E.4
Jain, A.5
Schreiber, M.J.6
-
87
-
-
34948869354
-
Vitamin D levels and early mortality among incident hemodialysis patients
-
Wolf M., Shah A., Gutierrez O., Ankers E., Monroy M., Tamez H., et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007, 72:1004-1013.
-
(2007)
Kidney Int
, vol.72
, pp. 1004-1013
-
-
Wolf, M.1
Shah, A.2
Gutierrez, O.3
Ankers, E.4
Monroy, M.5
Tamez, H.6
-
88
-
-
84455188819
-
Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies
-
Zittermann A., Iodice S., Pilz S., Grant W.B., Bagnardi V., Gandini S. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2012, 95:91-100.
-
(2012)
Am J Clin Nutr
, vol.95
, pp. 91-100
-
-
Zittermann, A.1
Iodice, S.2
Pilz, S.3
Grant, W.B.4
Bagnardi, V.5
Gandini, S.6
-
89
-
-
49649111989
-
Association of oral calcitriol with improved survival in nondialyzed CKD
-
Shoben A.B., Rudser K.D., de Boer I.H., Young B., Kestenbaum B. Association of oral calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol 2008, 19:1613-1619.
-
(2008)
J Am Soc Nephrol
, vol.19
, pp. 1613-1619
-
-
Shoben, A.B.1
Rudser, K.D.2
de Boer, I.H.3
Young, B.4
Kestenbaum, B.5
-
90
-
-
40449107836
-
Association of activated vitamin D treatment and mortality in chronic kidney disease
-
Kovesdy C.P., Ahmadzadeh S., Anderson J.E., Kalantar-Zadeh K. Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med 2008, 168:397.
-
(2008)
Arch Intern Med
, vol.168
, pp. 397
-
-
Kovesdy, C.P.1
Ahmadzadeh, S.2
Anderson, J.E.3
Kalantar-Zadeh, K.4
-
91
-
-
20844459261
-
Activated injectable vitamin D and hemodialysis survival: a historical cohort study
-
Teng M., Wolf M., Ofsthun M.N., Lazarus J.M., Hernan M.A., Camargo C.A., et al. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005, 16:1115-1125.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 1115-1125
-
-
Teng, M.1
Wolf, M.2
Ofsthun, M.N.3
Lazarus, J.M.4
Hernan, M.A.5
Camargo, C.A.6
-
92
-
-
83755206845
-
Seasonal variation in 25-hydroxyvitamin D concentrations in the cardiovascular health study
-
Shoben A.B., Kestenbaum B., Levin G., Hoofnagle A.N., Psaty B.M., Siscovick D.S., et al. Seasonal variation in 25-hydroxyvitamin D concentrations in the cardiovascular health study. Am J Epidemiol 2011, 174:1363-1372.
-
(2011)
Am J Epidemiol
, vol.174
, pp. 1363-1372
-
-
Shoben, A.B.1
Kestenbaum, B.2
Levin, G.3
Hoofnagle, A.N.4
Psaty, B.M.5
Siscovick, D.S.6
-
93
-
-
63849098416
-
Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004
-
Ginde A.A., Liu M.C., Camargo C.A. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009, 169:626-632.
-
(2009)
Arch Intern Med
, vol.169
, pp. 626-632
-
-
Ginde, A.A.1
Liu, M.C.2
Camargo, C.A.3
-
94
-
-
84857813265
-
25-hydroxyvitamin D: a difficult analyte
-
Carter G.D. 25-hydroxyvitamin D: a difficult analyte. Clin Chem 2012, 58:486-488.
-
(2012)
Clin Chem
, vol.58
, pp. 486-488
-
-
Carter, G.D.1
-
95
-
-
79959490945
-
Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship
-
Powe C.E., Ricciardi C., Berg A.H., Erdenesanaa D., Collerone G., Ankers E., et al. Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res 2011, 26:1609-1616.
-
(2011)
J Bone Miner Res
, vol.26
, pp. 1609-1616
-
-
Powe, C.E.1
Ricciardi, C.2
Berg, A.H.3
Erdenesanaa, D.4
Collerone, G.5
Ankers, E.6
-
96
-
-
84862496200
-
Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients
-
Bhan I., Powe C.E., Berg A.H., Ankers E., Wenger J.B., Karumanchi S.A., et al. Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients. Kidney Int 2012, 82:84-89.
-
(2012)
Kidney Int
, vol.82
, pp. 84-89
-
-
Bhan, I.1
Powe, C.E.2
Berg, A.H.3
Ankers, E.4
Wenger, J.B.5
Karumanchi, S.A.6
-
97
-
-
0031749608
-
Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats
-
Schwarz U., Amann K., Orth S.R., Simonaviciene A., Wessels S., Ritz E. Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int 1998, 53:1696-1705.
-
(1998)
Kidney Int
, vol.53
, pp. 1696-1705
-
-
Schwarz, U.1
Amann, K.2
Orth, S.R.3
Simonaviciene, A.4
Wessels, S.5
Ritz, E.6
-
98
-
-
1242351768
-
1,25Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat
-
Kuhlmann A., Haas C.S., Gross M.L., Reulbach U., Holzinger M., Schwarz U., et al. 1,25Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol 2004, 286:F526-F533.
-
(2004)
Am J Physiol Renal Physiol
, vol.286
-
-
Kuhlmann, A.1
Haas, C.S.2
Gross, M.L.3
Reulbach, U.4
Holzinger, M.5
Schwarz, U.6
-
99
-
-
0036073755
-
1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system
-
Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., Cao L.P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002, 110:229-238.
-
(2002)
J Clin Invest
, vol.110
, pp. 229-238
-
-
Li, Y.C.1
Kong, J.2
Wei, M.3
Chen, Z.F.4
Liu, S.Q.5
Cao, L.P.6
-
100
-
-
19944425466
-
Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems
-
Xiang W., Kong J., Chen S., Cao L.P., Qiao G., Zheng W., et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 2005, 288:E125-E132.
-
(2005)
Am J Physiol Endocrinol Metab
, vol.288
-
-
Xiang, W.1
Kong, J.2
Chen, S.3
Cao, L.P.4
Qiao, G.5
Zheng, W.6
-
101
-
-
79957485698
-
Extra-skeletal effects of vitamin D deficiency in chronic kidney disease
-
Chonchol M., Kendrick J., Targher G. Extra-skeletal effects of vitamin D deficiency in chronic kidney disease. Ann Med 2011, 43:273-282.
-
(2011)
Ann Med
, vol.43
, pp. 273-282
-
-
Chonchol, M.1
Kendrick, J.2
Targher, G.3
-
102
-
-
34548497123
-
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study
-
Fliser D., Kollerits B., Neyer U., Ankerst D.P., Lhotta K., Lingenhel A., et al. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 2007, 18:2600-2608.
-
(2007)
J Am Soc Nephrol
, vol.18
, pp. 2600-2608
-
-
Fliser, D.1
Kollerits, B.2
Neyer, U.3
Ankerst, D.P.4
Lhotta, K.5
Lingenhel, A.6
-
103
-
-
79951889923
-
FGF23 as a predictor of renal outcome in diabetic nephropathy
-
Titan S.M., Zatz R., Graciolli F.G., Dos Reis L.M., Barros R.T., Jorgetti V., et al. FGF23 as a predictor of renal outcome in diabetic nephropathy. Clin J Am Soc Nephrol 2011, 6:241-247.
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, pp. 241-247
-
-
Titan, S.M.1
Zatz, R.2
Graciolli, F.G.3
Dos Reis, L.M.4
Barros, R.T.5
Jorgetti, V.6
-
104
-
-
84857088991
-
Serum fibroblast growth factor-23 and risk of incident chronic kidney disease in older community-dwelling women
-
Semba R.D., Fink J.C., Sun K., Cappola A.R., Dalal M., Crasto C., et al. Serum fibroblast growth factor-23 and risk of incident chronic kidney disease in older community-dwelling women. Clin J Am Soc Nephrol 2012, 7:85-91.
-
(2012)
Clin J Am Soc Nephrol
, vol.7
, pp. 85-91
-
-
Semba, R.D.1
Fink, J.C.2
Sun, K.3
Cappola, A.R.4
Dalal, M.5
Crasto, C.6
-
105
-
-
77956159370
-
FGF23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment
-
Seiler S., Reichart B., Roth D., Seibert E., Fliser D., Heine G.H. FGF23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment. Nephrol Dial Transplant 2010, 25:3983-3989.
-
(2010)
Nephrol Dial Transplant
, vol.25
, pp. 3983-3989
-
-
Seiler, S.1
Reichart, B.2
Roth, D.3
Seibert, E.4
Fliser, D.5
Heine, G.H.6
-
106
-
-
77952996999
-
The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study
-
Parker B.D., Schurgers L.J., Brandenburg V.M., Christenson R.H., Vermeer C., Ketteler M., et al. The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med 2010, 152:640-648.
-
(2010)
Ann Intern Med
, vol.152
, pp. 640-648
-
-
Parker, B.D.1
Schurgers, L.J.2
Brandenburg, V.M.3
Christenson, R.H.4
Vermeer, C.5
Ketteler, M.6
-
107
-
-
79955890642
-
Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease
-
Taylor E.N., Rimm E.B., Stampfer M.J., Curhan G.C. Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease. Am Heart J 2011, 161:956-962.
-
(2011)
Am Heart J
, vol.161
, pp. 956-962
-
-
Taylor, E.N.1
Rimm, E.B.2
Stampfer, M.J.3
Curhan, G.C.4
-
108
-
-
80755172594
-
The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation
-
Seiler S., Cremers B., Rebling N.M., Hornof F., Jeken J., Kersting S., et al. The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation. Eur Heart J 2011, 32:2688-2696.
-
(2011)
Eur Heart J
, vol.32
, pp. 2688-2696
-
-
Seiler, S.1
Cremers, B.2
Rebling, N.M.3
Hornof, F.4
Jeken, J.5
Kersting, S.6
-
109
-
-
84856901155
-
FGF23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart
-
Ford M.L., Smith E.R., Tomlinson L.A., Chatterjee P.K., Rajkumar C., Holt S.G. FGF23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart. Nephrol Dial Transplant 2012, 27:727-733.
-
(2012)
Nephrol Dial Transplant
, vol.27
, pp. 727-733
-
-
Ford, M.L.1
Smith, E.R.2
Tomlinson, L.A.3
Chatterjee, P.K.4
Rajkumar, C.5
Holt, S.G.6
-
110
-
-
84856368350
-
FGF23 is associated with cardiac troponin T and mortality in hemodialysis patients
-
2011
-
Holden R.M., Beseau D., Booth S.L., Adams M.A., Garland J.S., Morton R.A., et al. FGF23 is associated with cardiac troponin T and mortality in hemodialysis patients. Hemodial Int 2012, 16:53-58. 2011.
-
(2012)
Hemodial Int
, vol.16
, pp. 53-58
-
-
Holden, R.M.1
Beseau, D.2
Booth, S.L.3
Adams, M.A.4
Garland, J.S.5
Morton, R.A.6
-
111
-
-
61849155234
-
Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients
-
Hsu H.J., Wu M.S. Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients. Am J Med Sci 2009, 337:116-122.
-
(2009)
Am J Med Sci
, vol.337
, pp. 116-122
-
-
Hsu, H.J.1
Wu, M.S.2
-
112
-
-
70450230670
-
Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
-
Mirza M.A., Larsson A., Melhus H., Lind L., Larsson T.E. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis 2009, 207:546-551.
-
(2009)
Atherosclerosis
, vol.207
, pp. 546-551
-
-
Mirza, M.A.1
Larsson, A.2
Melhus, H.3
Lind, L.4
Larsson, T.E.5
-
113
-
-
78649698386
-
Fibroblast growth factor 23 in chronic kidney disease: bridging the gap between bone mineral metabolism and left ventricular hypertrophy
-
Canziani M.E., Tomiyama C., Higa A., Draibe S.A., Carvalho A.B. Fibroblast growth factor 23 in chronic kidney disease: bridging the gap between bone mineral metabolism and left ventricular hypertrophy. Blood Purif 2011, 31:26-32.
-
(2011)
Blood Purif
, vol.31
, pp. 26-32
-
-
Canziani, M.E.1
Tomiyama, C.2
Higa, A.3
Draibe, S.A.4
Carvalho, A.B.5
-
114
-
-
79953880208
-
Serum fibroblast growth factor-23 (FGF23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients
-
Kirkpantur A., Balci M., Gurbuz O.A., Afsar B., Canbakan B., Akdemir R., et al. Serum fibroblast growth factor-23 (FGF23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients. Nephrol Dial Transplant 2011, 26:1346-1354.
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 1346-1354
-
-
Kirkpantur, A.1
Balci, M.2
Gurbuz, O.A.3
Afsar, B.4
Canbakan, B.5
Akdemir, R.6
-
115
-
-
49249104701
-
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
-
Gutierrez O.M., Mannstadt M., Isakova T., Rauh-Hain J.A., Tamez H., Shah A., et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008, 359:584-592.
-
(2008)
N Engl J Med
, vol.359
, pp. 584-592
-
-
Gutierrez, O.M.1
Mannstadt, M.2
Isakova, T.3
Rauh-Hain, J.A.4
Tamez, H.5
Shah, A.6
-
116
-
-
84860387372
-
Combined use of vitamin D status and FGF23 for risk stratification of renal outcome
-
Nakano C., Hamano T., Fujii N., Matsui I., Tomida K., Mikami S., et al. Combined use of vitamin D status and FGF23 for risk stratification of renal outcome. Clin J Am Soc Nephrol 2012, 7:810-819.
-
(2012)
Clin J Am Soc Nephrol
, vol.7
, pp. 810-819
-
-
Nakano, C.1
Hamano, T.2
Fujii, N.3
Matsui, I.4
Tomida, K.5
Mikami, S.6
-
117
-
-
84866396001
-
Residual renal function is an independent determinant of serum FGF23 levels in dialysis patients
-
Viaene L., Bammens B., Meijers B.K., Vanrenterghem Y., Vanderschueren D., Evenepoel P. Residual renal function is an independent determinant of serum FGF23 levels in dialysis patients. Nephrol Dial Transplant 2012, 27:2017-2022.
-
(2012)
Nephrol Dial Transplant
, vol.27
, pp. 2017-2022
-
-
Viaene, L.1
Bammens, B.2
Meijers, B.K.3
Vanrenterghem, Y.4
Vanderschueren, D.5
Evenepoel, P.6
-
118
-
-
59749105862
-
Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis
-
Wesseling-Perry K., Pereira R.C., Wang H., Elashoff R.M., Sahney S., Gales B., et al. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab 2009, 94:511-517.
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 511-517
-
-
Wesseling-Perry, K.1
Pereira, R.C.2
Wang, H.3
Elashoff, R.M.4
Sahney, S.5
Gales, B.6
-
119
-
-
81755163635
-
Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice
-
Farrow E.G., Yu X., Summers L.J., Davis S.I., Fleet J.C., Allen M.R., et al. Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proc Natl Acad Sci U S A 2011, 108:E1146-E1155.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
-
-
Farrow, E.G.1
Yu, X.2
Summers, L.J.3
Davis, S.I.4
Fleet, J.C.5
Allen, M.R.6
-
120
-
-
80655147297
-
Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans
-
Imel E.A., Peacock M., Gray A.K., Padgett L.R., Hui S.L., Econs M.J. Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans. J Clin Endocrinol Metab 2011, 96:3541-3549.
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 3541-3549
-
-
Imel, E.A.1
Peacock, M.2
Gray, A.K.3
Padgett, L.R.4
Hui, S.L.5
Econs, M.J.6
-
121
-
-
84863759120
-
Fibroblast growth factor 23 and inflammation in chronic kidney disease
-
Munoz Mendoza J., Isakova T., Ricardo A.C., Xie H., Navaneethan S., Anderson A.H., et al. Fibroblast growth factor 23 and inflammation in chronic kidney disease. Clin J Am Soc Nephrol 2012, 7:1155-1162.
-
(2012)
Clin J Am Soc Nephrol
, vol.7
, pp. 1155-1162
-
-
Munoz Mendoza, J.1
Isakova, T.2
Ricardo, A.C.3
Xie, H.4
Navaneethan, S.5
Anderson, A.H.6
-
122
-
-
78149412578
-
Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease
-
Manghat P., Fraser W.D., Wierzbicki A.S., Fogelman I., Goldsmith D.J., Hampson G. Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease. Osteoporos Int 2010, 21:1853-1861.
-
(2010)
Osteoporos Int
, vol.21
, pp. 1853-1861
-
-
Manghat, P.1
Fraser, W.D.2
Wierzbicki, A.S.3
Fogelman, I.4
Goldsmith, D.J.5
Hampson, G.6
-
123
-
-
84862095188
-
Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease
-
Wahl P., Xie H., Scialla J., Anderson C.A., Bellovich K., Brecklin C., et al. Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease. Diabetes Care 2012, 35:994-1001.
-
(2012)
Diabetes Care
, vol.35
, pp. 994-1001
-
-
Wahl, P.1
Xie, H.2
Scialla, J.3
Anderson, C.A.4
Bellovich, K.5
Brecklin, C.6
-
124
-
-
0024324631
-
Impact of left ventricular hypertrophy on survival in end-stage renal disease
-
Silberberg J.S., Barre P.E., Prichard S.S., Sniderman A.D. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989, 36:286-290.
-
(1989)
Kidney Int
, vol.36
, pp. 286-290
-
-
Silberberg, J.S.1
Barre, P.E.2
Prichard, S.S.3
Sniderman, A.D.4
-
125
-
-
0025280867
-
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
-
Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990, 322:1561-1566.
-
(1990)
N Engl J Med
, vol.322
, pp. 1561-1566
-
-
Levy, D.1
Garrison, R.J.2
Savage, D.D.3
Kannel, W.B.4
Castelli, W.P.5
|